Filter
3273
Filtered Results: 3273
Text search:
WHO
drug
use
indicators
Featured
Recommendations
274
New Publications
1007
Language
Document type
No document type
2108
Studies & Reports
502
Guidelines
334
Manuals
126
Strategic & Response Plan
126
Training Material
28
Fact sheets
24
Situation Updates
16
Infographics
7
Brochures
1
Online Courses
1
Countries / Regions
India
199
Kenya
116
Global
107
Ethiopia
92
Uganda
90
Nepal
81
Tanzania
78
Nigeria
76
Malawi
75
Western and Central Europe
69
South Africa
67
Zambia
64
Sierra Leone
63
Liberia
60
Ghana
57
Bangladesh
54
Latin America and the Carribbean
53
Myanmar / Burma
52
Rwanda
45
Namibia
41
Africa
39
Ukraine
33
Zimbabwe
33
Eastern Europe
33
Philippines
31
Lesotho
29
Cambodia
29
South–East Asia Region
29
Asia
25
Indonesia
21
Botswana
20
Congo, Democratic Republic of
17
Senegal
15
Burkina Faso
15
Eswatini/ Swaziland
15
Mozambique
14
Cameroon
11
Russia
11
Haiti
10
Eastern Europe and Central Asia
10
East and Southern Africa
10
Pakistan
10
Colombia
9
Syria
9
Albania
9
Georgia
9
Venezuela
8
West and Central Africa
8
Brazil
8
Middle East and North Africa
7
Thailand
6
Moldova
6
South Sudan
6
Laos
5
Peru
5
Guinea
5
Germany
5
Lebanon
5
Sudan
5
North Macedonia
4
Tajikistan
4
Benin
4
China
4
Armenia
4
USA
4
Western Pacific Region
4
North America
4
Argentina
4
Vietnam
4
Timor Leste/ East Timor
3
Mexico
3
El Salvador
3
Chile
3
Afghanistan
3
Jordan
3
Bolivia
3
Papua New Guinea
3
Sri Lanka
3
Bhutan
3
Iraq
3
Turkey
2
Kazakhstan
2
Iran
2
Estonia
2
Kyrgyzstan
2
Morocco
2
Mongolia
2
Saudi Arabia
2
Paraguay
2
Turkmenistan
2
France
2
United Kingdom
2
Portugal
2
Spain
2
Côte d’Ivoire / Ivory Coast
2
Central African Republic
2
Honduras
2
Mali
2
North Korea
1
Serbia
1
Gambia
1
Fiji
1
Singapore
1
Congo-Brazzaville
1
Niger
1
Qatar
1
Bulgaria
1
Italy
1
Hungary
1
Ireland
1
Gabon
1
Uruguay
1
Jamaica
1
Belgium
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Belarus
1
Nicaragua
1
Greece
1
Palestine
1
Poland
1
Libya
1
Somalia
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1495
Clinical Guidelines
254
Public Health
182
Women & Child Health
110
Key Resources
108
Pharmacy & Technologies
39
Capacity Building
35
Toolboxes
HIV
384
TB
302
Mental Health
227
AMR
183
NTDs
109
COVID-19
83
Pharmacy
77
Caregiver
66
NCDs
62
Rapid Response
57
Planetary Health
39
Disability
32
Global Health Education
32
Conflict
31
Refugee
27
Ebola & Marburg
25
Health Financing Toolbox
21
Polio
14
Natural Hazards
12
Cholera
11
Specific Hazards
9
Malaria
7
Zika
6
Social Ethics
4
Third edition.
The main changes within the third edition of the JEE tool include the split of the technical area National legislation, policy, and financing into two technical areas (Legal instruments and Financing); the drop of the technical area previously titled Reporting and the move of indicat...
This document provides guidance on how to implement contact screening and chemoprophylaxis with single-dose rifampicin. The contents are logically ordered: counselling and obtaining consent, identification and listing of index case, listing of contacts, tracing of contacts, screening of contacts, ad...
The 2020 Report analyzes global health spending for 190 countries from 2000 to 2018 and provides insights as to the health spending trajectory from the MDG era to the SDG era prior to the crisis of 2020. The report shows that global spending on health continually rose between 2000 and 2018 and reach...
This publication is a companion document to the NDVP National Deployment and Vaccination Plans guidance, which provides a framework for countries to develop their national strategies. As countries face challenges with erratic vaccine supplies, use of multiple vaccine products with different charact...
Assessment of non-communicable diseases (NCDs) service disruptions during the COVID-19 pandemic. Preliminary results.
Guidance on how to provide continuity for NCD programmes:• How to include NCDs in public health emergencies protocols?• How to develop national NCDs tool kits for use in emergen...
Maldives has made significant strides in the area of infectious disease prevention and control. This is exemplified by elimination of malaria from Maldives in 2015 and successes in TB control. In addition, Maldives is a front runner in infectious disease prevention through successful water, sanitati...
Fever Diagnostic Technology Landscape
recommended
1st edition.
Unitaid’s report describes a slate of new devices that can more efficiently identify dangerously ill children so that they can be treated immediately. These tools make it easier to recognize danger signs, and support integrated approaches to reducing childhood deaths from the three ...
Global Tuberculosis Report 2022 Factsheet
recommended
The World Health Organization Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and progress in the response, at global, regional and country levels.
The 2022 edition features data on disease trends and the response to the epidemic from 215 countries and area...
National action plans on antimicrobial resistance (AMR) often overlook the critical intersection of gender, despite evidence that exposure and susceptibility to infection, health-seeking behaviours, as well as antimicrobial prescribing and use patterns are all influenced by gender.
The aim of the people-centred framework is to help countries to develop fully prioritized and budgeted NSPs based on a culture of making full use of the available data, which are aligned with national planning cycles and which provide the basis for a robust national response that can accelerate prog...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
Monitoring of implementation of collaborative TB/HIV activities and evaluation of impact is critically important. This requires efficient monitoring and evaluation system so as to establish accountability mechanisms between programmes, the population they serve, and donors. The Guide to monitoring a...
The "Global NCD action plan" provides a road map and a menu of policy options for countries to take in order to attain the 9 voluntary global targets, including that of a 25% relative reduction in premature mortality from cardiovascular diseases, cancer, diabetes or chronic respiratory diseases by 2...
The country profiles incorporate facts indicating the national status of medical devices in areas such as: medical device policies, regulations, incorporation, lists, inventories, nomenclature, health technology assessment, management, and biomedical engineering resources. This publication is int...
Global Tuberculosis Report 2021
recommended
Each year, the WHO Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
The...
Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. Diabetes is an important public health problem, one of four priority noncom...
Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. Diabetes is an important public health problem, one of four priority noncom...
It summarizes guidance on how to manage – and when to refer – children and adolescents presenting with common complaints and conditions. It includes information to enable primary health care providers to coordinate the continued care of children and adolescents with long-term conditions and dise...
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of CVD diseases. Affordable essential medicines and t...
These WHO guidelines which were updated in 2018, are valid for any country and suitable to local adaptations, and take account of the strength of available scientific evidence, the cost and resource implications, and patient values and preferences.
The 2018 edition of the guidelines includes the re...
